XYRA LLC, a private biopharmaceutical company, is committed to developing innovative therapies for cardiac rhythm disorders with high unmet needs. With the widespread use of FDA-approved wearable ...
Genomics' latest groundbreaking research, showcased at the Bupa Health Symposium, shows that a person's genetic background is a key driver for their BMI and therefore is crucial to understanding their ...
Dr. Howe, an assistant professor of biochemistry and molecular biology in RFU's Center for Proteomics and Molecular Therapeutics and Center for Cancer Cell Biology, Immunology and ...
The Center for Innovative GYN Care (CIGC) continues to lead the way in women's health by providing the Laparoscopic Assisted Abdominal Myomectomy (LAAM) procedure as an effective treatment for ...
Explore how mAbs are transforming disease treatment, the evolution from murine to humanized antibodies, and the impact of biosimilar antibodies on cost-effective therapies.